Works matching IS 10781552 AND DT 2025 AND VI 31 AND IP 3


Results: 21
    1
    2

    Talimogene laherparepvec (T-VEC) as a treatment for melanoma: A systematic review.

    Published in:
    Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 3, p. 481, doi. 10.1177/10781552241312920
    By:
    • Alla, Sai Santhosha Mrudula;
    • Tekuru, Yogesh;
    • Lokesh, Moraboina Sai;
    • Alla, Deekshitha;
    • Tvisha, Patel;
    • Tirupati, Soujanya;
    • Singh, Aradhya;
    • Tejaswini, Yeshala;
    • Mahmood, Mariya;
    • Siingh, Nanki Pratap;
    • Vineetha, Bodipudi
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11

    A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy.

    Published in:
    Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 3, p. 430, doi. 10.1177/10781552241242096
    By:
    • Musicco, Felice;
    • Fulgenzio, Chiara;
    • Malfa, Antonia La;
    • Jannitti, Nicoletta;
    • Vitiello, Antonietta;
    • Carpano, Silvia;
    • Fusco, Francesca;
    • Cappuzzo, Federico;
    • Terrenato, Irene;
    • Sperduti, Isabella;
    • Polidori, Piera;
    • Tarantino, Domenico;
    • Cerbo, Lidia Di;
    • Pani, Marcello;
    • Isgrò, Valentina;
    • Lasala, Ruggero
    Publication type:
    Article
    12

    Securing the oral and enteral oncopediatric chemotherapy process in pediatric oncology: Introduction of the ENFit™ standard in a controlled-atmosphere area and implementation of a dispensing service of medications to outpatients circuit with advice on proper use

    Published in:
    Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 3, p. 422, doi. 10.1177/10781552241241062
    By:
    • Poutrain, Elise;
    • Abelé-Naveau, Marie;
    • Baltora, Marion;
    • Villain, Alexandre;
    • Sakji, Ilyes;
    • Strobbe, Geoffrey;
    • Marliot, Guillaume
    Publication type:
    Article
    13
    14

    Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

    Published in:
    Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 3, p. 404, doi. 10.1177/10781552241241004
    By:
    • Yildirim, Mahmut Emre;
    • Karadurmuş, Nuri;
    • Ökten, İlker Nihat;
    • Türk, Hacı Mehmet;
    • Urakçı, Zuhat;
    • Arslan, Çağatay;
    • Çelik, Sinemis;
    • Dane, Faysal;
    • Şendur, Mehmet Ali Nahit;
    • Bilir, Cemil;
    • Karabulut, Bülent;
    • Cicin, İrfan;
    • Çubukçu, Erdem;
    • Karaca, Mustafa;
    • Ozcelik, Melike;
    • Artaç, Mehmet;
    • Tanrikulu, Eda;
    • Alacacioglu, Ahmet;
    • Açıkgöz, Özgür;
    • Öven, Başak
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21